Literature DB >> 28467100

Augmented Versus Nonaugmented Repair of Acute Achilles Tendon Rupture: A Systematic Review and Meta-analysis.

Yi-Jun Zhang1, Chi Zhang1, Quan Wang1, Xiang-Jin Lin1.   

Abstract

BACKGROUND: Although simple end-to-end repair of the Achilles tendon is common, many augmented repair protocols have been implemented for acute Achilles tendon rupture. However, whether augmented repair is better than nonaugmented repair of an acute Achilles tendon rupture is still unknown.
PURPOSE: To conduct a meta-analysis to determine whether augmented surgical repair of an acute Achilles tendon rupture improved subjective patient satisfaction without an increase in rerupture rates. Secondary outcomes assessed included infections, ankle range of motion, calf muscle strength, and minor complications. STUDY
DESIGN: Meta-analysis.
METHODS: A systematic literature search of peer-reviewed articles was conducted to identify all randomized controlled trials (RCTs) comparing augmented repair and nonaugmented repair for acute Achilles tendon rupture from January 1980 to August 2016 in the electronic databases of PubMed, Web of Science (SCI-E/SSCI/A&HCI), and EMBASE. The keywords (Achilles tendon rupture) AND (surg* OR operat* OR repair* OR augment* OR non-augment* OR end-to-end OR sutur*) were combined, and results were limited to human RCTs and controlled clinical trials published in the English language. Four RCTs involving 169 participants were eligible for inclusion; 83 participants were treated with augmented repair and 86 were treated with nonaugmented repair.
RESULTS: Augmented repair led to similar responses when compared with nonaugmented repair for acute Achilles tendon rupture (93% vs 90%, respectively; P = .53). The rerupture rates showed no significant difference for augmented versus nonaugmented repair (7.2% vs 9.3%, respectively; P = .69). No differences in superficial and deep infections occurred in augmented (7 infections) and nonaugmented (8 infections) repair groups during postoperative follow-up ( P = .89). The average incisional infection rate was 8.4% with augmented repair and 9.3% with nonaugmented repair. No significant differences in other complications were found between augmented (7.2%) and nonaugmented (8.1%) repair ( P = .80).
CONCLUSION: Augmented repair, when compared with nonaugmented repair, was not found to improve patient satisfaction or reduce rerupture rate or infection rate. These conclusions are based on 4 trials with small sample sizes, and larger randomized trials are required to confirm these results.

Entities:  

Keywords:  Achilles tendon rupture; augmented repair; nonaugmented repair

Mesh:

Year:  2017        PMID: 28467100     DOI: 10.1177/0363546517702872

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  4 in total

1.  Lower extremity work along with triceps surae structure and activation is altered with jumping after Achilles tendon repair.

Authors:  Jennifer A Zellers; Adam R Marmon; Anahid Ebrahimi; Karin Grävare Silbernagel
Journal:  J Orthop Res       Date:  2019-03-21       Impact factor: 3.494

2.  Achilles Tendon Lesions - Part 2: Ruptures.

Authors:  Nacime Salomão Barbachan Mansur; Lucas Furtado Fonseca; Fábio Teruo Matsunaga; Daniel Soares Baumfeld; Caio Augusto de Souza Nery; Marcel Jun Sugawara Tamaoki
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2020-04-29

3.  No difference in strength and clinical outcome between early and late repair after Achilles tendon rupture.

Authors:  Michael R Carmont; Jennifer A Zellers; Annelie Brorsson; Karin Grävare Silbernagel; Jón Karlsson; Katarina Nilsson-Helander
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-12-29       Impact factor: 4.342

4.  Prevention of postoperative adhesions after flexor tendon repair with acellular dermal matrix in Zones III, IV, and V of the hand: A randomized controlled (CONSORT-compliant) trial.

Authors:  Yeon Ji Lee; Hyun Jung Ryoo; Hyung-Sup Shim
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.